Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

The multifaceted roles of autophagy in tumors-implications for breast cancer.

Debnath J.

J Mammary Gland Biol Neoplasia. 2011 Sep;16(3):173-87. doi: 10.1007/s10911-011-9223-3. Epub 2011 Jul 21. Review.

2.

The Evolving, Multifaceted Roles of Autophagy in Cancer.

Liu J, Debnath J.

Adv Cancer Res. 2016;130:1-53. doi: 10.1016/bs.acr.2016.01.005. Epub 2016 Feb 23. Review.

PMID:
27037750
3.
4.

Apoptosis and autophagy in mammary gland remodeling and breast cancer chemotherapy.

Motyl T, Gajkowska B, Zarzyńska J, Gajewska M, Lamparska-Przybysz M.

J Physiol Pharmacol. 2006 Nov;57 Suppl 7:17-32. Review.

PMID:
17228094
5.

γ-Tocotrienol-induced autophagy in malignant mammary cancer cells.

Tiwari RV, Parajuli P, Sylvester PW.

Exp Biol Med (Maywood). 2014 Jan;239(1):33-44. doi: 10.1177/1535370213511022. Epub 2013 Nov 14.

PMID:
24231340
6.

Autophagy regulates keratin 8 homeostasis in mammary epithelial cells and in breast tumors.

Kongara S, Kravchuk O, Teplova I, Lozy F, Schulte J, Moore D, Barnard N, Neumann CA, White E, Karantza V.

Mol Cancer Res. 2010 Jun;8(6):873-84. doi: 10.1158/1541-7786.MCR-09-0494. Epub 2010 Jun 8.

7.

Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment.

Martinez-Outschoorn UE, Trimmer C, Lin Z, Whitaker-Menezes D, Chiavarina B, Zhou J, Wang C, Pavlides S, Martinez-Cantarin MP, Capozza F, Witkiewicz AK, Flomenberg N, Howell A, Pestell RG, Caro J, Lisanti MP, Sotgia F.

Cell Cycle. 2010 Sep 1;9(17):3515-33. Epub 2010 Sep 9.

8.

Role of autophagy in breast cancer.

Karantza-Wadsworth V, White E.

Autophagy. 2007 Nov-Dec;3(6):610-3. Epub 2007 Aug 14.

9.

Autophagy and tumorigenesis.

Roy S, Debnath J.

Semin Immunopathol. 2010 Dec;32(4):383-96. doi: 10.1007/s00281-010-0213-0. Epub 2010 Jun 30. Review.

10.

Autophagy opposes p53-mediated tumor barrier to facilitate tumorigenesis in a model of PALB2-associated hereditary breast cancer.

Huo Y, Cai H, Teplova I, Bowman-Colin C, Chen G, Price S, Barnard N, Ganesan S, Karantza V, White E, Xia B.

Cancer Discov. 2013 Aug;3(8):894-907. doi: 10.1158/2159-8290.CD-13-0011. Epub 2013 May 6.

11.

Triazole analog 1-(1-benzyl-5-(4-chlorophenyl)-1H-1,2,3-triazol-4-yl)-2-(4-bromophenylamino)-1-(4-chlorophenyl)ethanol induces reactive oxygen species and autophagy-dependent apoptosis in both in vitro and in vivo breast cancer models.

Hamidullah, Saini KS, Ajay A, Devender N, Bhattacharjee A, Das S, Dwivedi S, Gupt MP, Bora HK, Mitra K, Tripathi RP, Konwar R.

Int J Biochem Cell Biol. 2015 Aug;65:275-87. doi: 10.1016/j.biocel.2015.06.016. Epub 2015 Jun 24.

PMID:
26115963
12.

Lysosomal transmembrane protein LAPTM4B promotes autophagy and tolerance to metabolic stress in cancer cells.

Li Y, Zhang Q, Tian R, Wang Q, Zhao JJ, Iglehart JD, Wang ZC, Richardson AL.

Cancer Res. 2011 Dec 15;71(24):7481-9. doi: 10.1158/0008-5472.CAN-11-0940. Epub 2011 Oct 28.

13.

A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer.

Prosperi JR, Goss KH.

Curr Drug Targets. 2010 Sep;11(9):1074-88. Review.

PMID:
20545611
14.

Recent advances in breast cancer biology.

Schultz LB, Weber BL.

Curr Opin Oncol. 1999 Nov;11(6):429-34. Review.

PMID:
10550005
15.

Regulator of G protein signaling 6 is a novel suppressor of breast tumor initiation and progression.

Maity B, Stewart A, O'Malley Y, Askeland RW, Sugg SL, Fisher RA.

Carcinogenesis. 2013 Aug;34(8):1747-55. doi: 10.1093/carcin/bgt128. Epub 2013 Apr 18.

16.

Inhibiting breast cancer progression by exploiting TGFbeta signaling.

Baxley SE, Serra R.

Curr Drug Targets. 2010 Sep;11(9):1089-102. Review.

PMID:
20545612
17.

Integrating autophagy and metabolism in cancer.

Cheong H.

Arch Pharm Res. 2015 Mar;38(3):358-71. doi: 10.1007/s12272-015-0562-2. Epub 2015 Jan 24. Review.

PMID:
25614051
18.

Cholesterol-induced mammary tumorigenesis is enhanced by adiponectin deficiency: role of LDL receptor upregulation.

Liu J, Xu A, Lam KS, Wong NS, Chen J, Shepherd PR, Wang Y.

Oncotarget. 2013 Oct;4(10):1804-18.

19.

The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.

Aprelikova O, Chen K, El Touny LH, Brignatz-Guittard C, Han J, Qiu T, Yang HH, Lee MP, Zhu M, Green JE.

Clin Epigenetics. 2016 Apr 14;8:38. doi: 10.1186/s13148-016-0205-6. eCollection 2016.

20.

Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14.

Asselin-Labat ML, Sutherland KD, Vaillant F, Gyorki DE, Wu D, Holroyd S, Breslin K, Ward T, Shi W, Bath ML, Deb S, Fox SB, Smyth GK, Lindeman GJ, Visvader JE.

Mol Cell Biol. 2011 Nov;31(22):4609-22. doi: 10.1128/MCB.05766-11. Epub 2011 Sep 19.

Supplemental Content

Support Center